The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
Saved in:
| Title: | The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. |
|---|---|
| Authors: | Volkmann A; Bavarian Nordic, Germany., Williamson AL; Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa., Weidenthaler H; Bavarian Nordic, Germany., Meyer TPH; Bavarian Nordic, Germany., Robertson JS; Independent Adviser, United Kingdom., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA., Evans E; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA., Smith ER; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA., Chen RT; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA. |
| Corporate Authors: | Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG |
| Source: | Vaccine [Vaccine] 2021 May 21; Vol. 39 (22), pp. 3067-3080. Date of Electronic Publication: 2020 Oct 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
